CC BY
833 3
2022
GAngeloudi E, Bekiari E, Pagkopoulou E, Anyfanti P, Doumas M, Garyfallos A, Dimitroulas T.
This work is licensed under a Creative Commons Attribution 4.0 International L
RESEARCH PROTOCOL
Study of Peripheral Microcirculation Assessed by Nailfold Video-Capillaroscopy and Association with Markers of Endothelial Dysfunction and Inflammation in Rheumatoid Arthritis
Elena Angeloudi1 , Eleni Bekiari1 , Eleni Pagkopoulou2 , Panagiota Anyfanti2 , Michael Doumas3 , Alexandras Garyfallos2 , Theodoros Dimitroulas2
1Second Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Greece, 2Fourth Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Greece, 3Second Propaedeutic Department of Internal Medicine, Hippokration Hospital, Aristotle University of Thessaloniki, Greece
ABSTRACT
Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease that primarily affects synovial joints and is associated with increased cardiovascular (CV) mortality and morbidity. This association is only partially attributed to the presence of classic CV disease risk factors, and is strongly associated with characteristics of disease itself namely systemic chronic inflammation and autoimmune activation. Growing evidence suggests that microvascular endothelial dysfunction contributes to the initiation and progression of vascular disease. Nailfold capillaroscopy is a non-invasive method that evaluates the morphology and the structure of nailfold capillaries. Extension of this method is the Nailfold Videocapillaroscopy (NVC), which provides the possibility of combining functional and anatomical study of peripheral microcirculation. The present cross-sectional study aims to evaluate using NVC the peripheral microcirculation in adult patients with RA and investigate the associations between structural and functional indices of digital capillaries with markers of atherosclerosis.
Mediterr J Rheumatol 2022;33(3):375-9 https://doi.org/10.31138/mjr.33.3.375
Article Submitted: 5 Aug 2022; Article Accepted: 31 Aug 2022; Available Online: 30 Sep 2022
Keywords: microcirculation, nailfold videocapillaroscopy, rheumatoid arthritis, endothelial dysfunction, atherosclerosis, inflammation markers
Corresponding Author:
Elena Angeloudi, MD, MSc
Second Department of Internal Medicine,
Hippokration Hospital
Aristotle Univeristy of Thessaloniki
Konstantinoupoleos 49, 54642
Thessaloniki, Greece
Tel/Fax: +30 2310 892246
E-Mail: [email protected]
INTRODUCTION
Rheumatoid Arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent inflammatory synovitis that usually affects peripheral joints with symmetrical distribution.1 RA has been associated with reduced survival by 3-18 years compared to the general population2 with the leading cause of premature death being CV disease.3 In a meta-analysis involving 41,490 patients with RA, the risk of
CV disease was 48% higher in patients with RA compared to the general population.4 These rates appear to be only partially correlated with the presence of classic cardiovascular risk factors, such as dyslipidaemia, hypertension, and smoking, thus indicating RA itself as an independent CV disease risk fac-tor.5 The aetiology of high CV risk in RA is not fully understood.6-8 However, RA related chronic high grade systemic inflammation exerts detrimental effects
Cite this article as: Angeloudi E, Bekiari E, Pagkopoulou E, Anyfanti P, Doumas M, Garyfallos A, Dimitroulas T. Study of Peripheral Microcircu- 375 lation Assessed by Nailfold Video-Capillaroscopy and Association with Markers of Endothelial Dysfunction and Inflammation in Rheumatoid Arthritis. Mediterr J Rheumatol 2022;33(3):375-9.
on endothelium haemostasis such as reduction of nitric oxide production, dysregulation of vascular tone and activation of endothelial cells all of which culminate in atherosclerosis.9 In RA, vascular injury affects both micro- and microvasculature although most studies have focused mostly on macrovascular atherosclerotic coronary heart disease.10-12
The better understanding of the relationship between vascular wall damage and systemic inflammation, as well as the study of early atherosclerotic disease in RA have gained great research interest to the extent that RA is considered the most studied systemic inflammatory disease in this field. In addition, the presence of subclinical atherosclerosis in RA is common and until recently underestimated in clinical practice. The main cardiovascular risk assessment indices used primarily in patients with RA are Pulse Wave Velocity (PWV) and Carotid Intima-Media Thickness (cIMT).13,14 In view of microcirculation several studies and metanalyses have shown impairment of vascular function which in some cases may precede macro-vascular atherosclerotic disease.15-18 Nailfold capillaros-copy is a non-invasive, reproducible capillary imaging technique that examines the morphology and number of capillaries using a microscopic magnification system after placing a drop of cedar oil on the skin.19 NC is an established method for the diagnostic work out of patients with Raynaud's and its implications are currently expanding in other clinical aspects of systemic sclerosis patients such as lung and cardiac involvement.20 An extension of the method of simple capillaroscopy is the video-capillaroscopy (NVC), which provides the possibility of structural and functional assessment of the microcirculation in the digital capillaries. The method enables the representation of the differences, in relation to rest, in the number of non-perfused capillaries after venous congestion or reactive hyperaemia after arterial occlusion (post-occlusive reactive hyperaemia). Thus, functional changes of the capillaries, in addition to the structural ones, are documented. For example, patients with arterial hypertension, who were the first group of non-rheumatic patients to have their microcirculation studied, showed reduced capillary density, both at rest and during venous congestion or after arterial occlusion.21-26 A few studies have investigated peripheral microcirculation in RA individuals. Rajaei et al.27 studied 430 patients with RA and recorded their capillary findings. The researchers observed an increased frequency of morphological capillary changes, in particular increased angiogenesis and severe capillary distortion (tortuosity). An earlier study28 also found that severe distortion and elongated capillaries are the main features of patients with RA, which concurs with previous observation,2930 demonstrating low rates of scleroderma morphological lesions in patients with RA. Lin et al.31 also showed that the most prominent capillary finding in RA is increased
capillary distortion and elongated capillaries. However, the association between NVC morphologic and functional abnormalities with indices of macrovascular disease in this population has not been extensively investigated. The current study aims to evaluate peripheral microcirculation assessed by NVC, in patients with RA and to explore the potential associations between structural and functional alterations of digital capillaries with markers of atherosclerosis such as cIMT and arterial stiffness.
METHODS
Study Design and Setting
This is a prospective cross-sectional observational study, which will be conducted in the Fourth Internal Medicine Department at Hippokration General Hospital of Thessaloniki in collaboration with the Hypertension Laboratory of the Second Propaedeutic Department of Internal Medicine, Hippokration General Hospital of Thessaloniki. The study received approval from the Aristotle University Ethics Committee. All participants will give informed consent before study entry.
Inclusion Criteria
This study enrols patients > 18 years old with RA based on the criteria of the American College of Rheumatology and the European Society of Rheumatology (ACR / EU-LAR 2010) who are either already attending or attending for the first time the Rheumatology Division of the 4th Department of Internal Medicine, Hippokration General Hospital of Thessaloniki. Patients will have the full ability to understand and provide written signed consent to participate in the study after being informed.
Exclusion criteria
The doctoral dissertation protocol will exclude patients with known, confirmed by biopsy, active malignancy, patients with myocardial infarction or unstable angina episode in the last 3 months and/or congestive heart failure category IV, according to the criteria of New York Heart Association as well as patients who refuse to participate in the study and sign the consent form. Also, patients with diabetes mellitus, chronic kidney disease stage 4 or 5 with eGFR <30ml/min/1.73m2 for at least three months will be excluded as well as patients with a change in anti-hypertensive treatment in the last month before the start of the study. Finally, patients with previous vascular carotid surgery due to anatomical difficulty in assessing the cIMT index will be excluded.
Study Overview
Complete medical history, including medication record and smoking habits will be obtained from all participants. Patients will undergo clinical examination, office blood pressure measurement and blood sample collection for routine haematology, biochemistry including lipid profile
and blood glucose and inflammatory markers. Centri-fuged samples will be stored in a deep freezer (-70oC) to determine Asymmetric Dimethylarginine (ADMA) levels after collection of all samples.
Following the blood sampling, the patients will undergo tonometric measurement of arterial stiffness and ultrasound determination of cIMT using SphygmoCor and Vivid 7 of General Electric devices, respectively. Finally, the patient will be transferred to the Rheumatology Division of the Fourth Department of Internal Medicine, in order to have NVC with the use of the Optilia Digital Capillaroscope device. After the end of the evaluation, the patient will receive from the rheumatologist the medical instructions that correspond to the specific scheduled visit and the monitoring within the protocol will be ceased. All vascular assessments will be performed at the same time period for each patient within 24 hours before or after blood sample collection.
Study Procedures
Measurements with the SphygmoCor device The radial artery applanation tonometry method is used to record the pulse waveform in the carotid artery, using the SphygmoCor device, AtCor Medical Pty Ltd, Sydney, NSW, Australia. This method will calculate the augmentation index (AIx) based on the augmentation pressure (systolic pressure minus the inflection pressure) divided by the pulse pressure (systolic minus diastolic pressure), expressed as a percentage.32 As the AIx is dependent on the transit time of the reflected wave and the time of arrival of the reflected wave during the pressure pulse, it is also sensitive to heart rate. The SphygmoCor software reports the AIx at the patient's current heart rate, as well as giving an AIx corrected to a heart rate of 75 bpm using a regression to the population heart rate dependency of the Aix.33 PWV will then be determined in each patient as a marker of arterial stiffness. The carotid and femoral pulse is acquired by applanation tonometry sequentially, allowing a single operator to acquire the measurement. The transit time from the R-wave of the simultaneously acquired electrocardiogram to the foot of the carotid and femoral pulse is measured.34 The difference between these 2 transit times is divided by distances measured from the body surface to estimate the arterial path length in order to calculate the carotid-femoral PWV. The length of the vascular pathway is calculated by measuring linear distances between the palpation point of the carotid artery with the supernatant incision and the supernatural incision with the palpation point of the femoral artery.35
cIMT Measurement
Ultrasound determination of cIMT of the two common carotid arteries will be performed using Vivid 7 of General Electrics based on the consensus of Mannheim.36 The cIMT measurement will be performed in a region free of
plaque where there is a standard double-line pattern, and the measurements are more accurate and reproducible. The sections of the arterial walls will be evaluated in a longitudinal view, strictly perpendicular to the ultrasound beam, with both walls being visible to achieve diameter measurements.37 The optimal diameter will be obtained during dilation by looking for the minimum diameter during the cardiac cycle. The cIMT will be measured on the proximal vessel wall, as the cIMT values of the distal wall are less reliable. At least 10mm in length, an arterial section will take a high-resolution image to perform a series of reproducible measurements.38
Nailfold Videocapillaroscopy
NVC is an established non-invasive method to assess the capillary vasculature of the digital arteries, which provides information on the structural and functional abnormalities of the capillaries. It is performed at room temperature (22-23°C) with the patient seated and resting for 15 minutes NVC will be performed at the Fourth Internal Medicine Department at Hippokrateion Hospital using an Optilia Digital Capillaroscope. Pictures and videos of 15 seconds duration will be captured using the 200x magnification video camera from the second to the fifth finger of each hand. The images will be analysed with Optipix capillaroscopy software 1.7.x on a computer. The NVC parameters to be measured are: capillary density, capillary width and length (|jm), the presence of micro-bleeding, oedema, thrombi, and the presence of any abnormalities in the morphology or disorder of capillary architecture. These parameters will be determined on each nail (except thumbs) and the average of all measurements for each patient will be calculated at the end.39 In addition to the quantitative and qualitative parameters, a functional evaluation of the changes in capillary density will be performed using digital video in three phases, as follows: the capillaries will be imaged on the skin of the distal phalanges of the dorsal region of the third and fourth fingers of the two upper limbs. The imaging will be about 4.5mm near the terminal row of capillaries in the middle of nailfold. The researcher will select a skin area of 1 mm2. Capillary density will be measured in three conditions: a) baseline capillary density, which is defined as the number of continuously filled red blood cells per 1 mm2 of skin and measured for 15 seconds; b) capillary density during hyperaemia after arterial occlusion, which is evaluated after 4 minutes of arterial occlusion [use a microscopic finger cuff applied to the base of the finger under study and 'filled' at hypersystolic pressure (260mmHg) for 4 minutes]. Immediately after the release of the cuff, all (continuously and intermittently) paid capillaries are counted for 15 seconds and c) venous congestion density using a cuff at 60mmHg for two minutes and then all (continuously and intermittently) capillaries will be measured for 15 seconds.40-43
Outcomes Primary outcomes
A. Investigation of the correlation between capillary density at baseline, after 4-min arterial occlusion and after 2-min venous occlusion, with atherosclerosis indices (cIMT, PWV, AIX)
Secondary Outcomes
A. Investigation of the correlation between microangiopathy findings, as assessed by videocapillaroscopy, and biochemical markers of endothelial function, such as ADMA, CRP, and uric acid
B. Investigation of the correlation between microangiopathy findings, as assessed by video-capillaroscopy, and overall cardiovascular risk
Sample Size
Published studies44 have indicated a statistically significant correlation between basal capillary density and markers microvascular disease in patients with systemic sclerosis (Pearson's correlation coefficient R = 0.35, p-value = 0.044). In the international literature45,46 it has a significant correlation of capillary density with factors such as gender, age, smoking, hypertension, and diabetes, while the possible effect of taking organic factors as the main medication. According to the above, one sample of 105 people has 80% statistical power to detect an expected effect size equal to 0.15 in a multiple regression model with 7 independent variables assuming type I error, a = 0.05.47-50 In addition, to ensure the completeness of all statistical checks our sample will includes at least ten people in each one (one in ten rule)51 from the above risk factors (gender, age group, smokers, people with hypertension, people with diabetes).
ANTICIPATED BENEFITS
The research hypothesis that in patients with RA a correlation is observed between the parameters of NVC with markers of endothelial dysfunction and inflammation, may contribute to the introduction of a new non-invasive reliable method for assessing the severity and progression of the peripheral microvascular disease in patients with RA. It will also help to understand the pathophysi-ology of vascular damage at the microvascular level and may be able to contribute to better assessment of CV risk in patients with RA. This may extend the use of NVC, as a reliable, reproducible and at the same time simple and non-invasive, complementary method for the assessment stratification of CV risk in this population.
ETHICAL APPROVAL
The study received approval from the Aristotle University Ethics Committee.
FUNDING
This study will be funded by the Greek Rheumatology Society & Professional Association of Rheumatologists.
CONFLICT OF INTEREST
The authors declare no conflicts of interest.
REFERENCES
1. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and manage-
ment. Am J Med 2007 Nov;120(11):936-9.
2. Giles JT. Cardiovascular disease in rheumatoid arthritis: Current per-
spectives on assessing and mitigating risk in clinical practice. Best Pract Res Clin Rheumatol 2015 Aug-Dec;29(4-5):597-613.
3. López-Mejías R, Castañeda S, González-Juanatey C, Corrales A,
Ferraz-Amaro I, Genre F, et al. Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers. Autoimmun Rev 2016 Nov;15(11):1013-1030.
4. van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser
M, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2009 Sep;68(9):1395-400.
5. Semb AG, Ikdahl E, Kerola AM, Wibetoe G, Sexton J, Crowson CS, et
al; SURF-RA collaborators. Mediterr J Rheumatol 2022;33(2):201-17.
6. van Breukelen-van der Stoep DF, Klop B, van Zeben D, Hazes JM,
Castro Cabezas M. Cardiovascular risk in rheumatoid arthritis: how to lower the risk? Atherosclerosis 2013 Nov;231(1):163-72.
7. Erb N, Pace AV, Douglas KM, Banks MJ, Kitas GD. Risk assessment
for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2004;33(5):293-9.
8. Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A.
Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 2011 Mar;78(2):179-83
9. Venetsanopoulou AI, Pelechas E, Voulgari PV, Drosos AA. The lipid
paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int 2020 Aug;40(8):1181-91.
10. Prati C, Demougeot C, Guillot X, Godfrin-Valnet M, Wendling D. Endothelial dysfunction in joint disease. Joint Bone Spine 2014 Oct;81(5):386-91.
11. Daiber A, Steven S, Weber A, Shuvaev VV, Muzykantov VR, Laher I. Targeting vascular (endothelial) dysfunction. Br J Pharmacol. 2017 Jun;174(12):1591-1619
12. Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K, Beyer AM. The Human Microcirculation: Regulation of Flow and Beyond. Circ Res 2016 Jan 8;118(1):157-72.
13. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. H; European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006 Nov;27(21):2588-605.
1 4. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and metaanalysis. J Am Coll Cardiol 2010 Mar 30;55(13):1318-27.
15. Sandoo A, Veldhuijzen van Zanten JJ, Metsios GS, Carroll D, Kitas GD. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2011 Nov;50(11):2125-39.
16. Sandoo A. Important Considerations for Examining Endothelial Dysfunction in Rheumatoid Arthritis. Mediterr J Rheumatol 2017 Sep 29;28(3):112-5.
17. Sandoo A, Carroll D, Metsios GS, Kitas GD, Veldhuijzen van Zanten JJ. The association between microvascular and macrovascular en-dothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2011 Jun 21;13(3):R99.
18. Sandoo A, Kitas GD, Carroll D, Veldhuijzen van Zanten JJ. The role
of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther 2012 May 17;14(3):R117.
19. Cutolo M, Sulli A, Smith V. How to perform and interpret capillaros-copy. Best Pract Res Clin Rheumatol 2013 Apr;27(2):237-48
20. Repa A, Avgoustidis N, Kougkas N, Bertsias G, Zafiriou M, Sid-iropoulos P. Nailfold Videocapillaroscopy as a Candidate Biomark-er for Organ Involvement and Prognosis in Patients with Systemic Sclerosis. Mediterr J Rheumatol 2019 Mar 28;30(1):48-50.
21. Serné EH, Gans RO, ter Maaten JC, Tangelder GJ, Donker AJ, Stehouwer CD. Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension 2001 Aug;38(2):238-42.
22. Antonios TF, Rattray FE, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci 1999;97(4):523-8.
23. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 1999 Oct;34(4 Pt 1):655-8.
24. Martens RJ, Henry RM, Houben AJ, van der Kallen CJ, Kroon AA, Schalkwijk CG, et al. Capillary Rarefaction Associates with Albuminuria: The Maastricht Study. J Am Soc Nephrol 2016 Dec;27(12):3748-3757.
25. Serné EH, Stehouwer CD, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJ, et al. Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 1999 Feb 23;99(7):896-902.
26. Draaijer P, de Leeuw PW, van Hooff JP, Leunissen KM. Nailfold capillary density in salt-sensitive and salt-resistant borderline hypertension. J Hypertens 1993 Nov;11(11):1195-8.
27. Rajaei A, Dehghan P, Amiri A. Nailfold capillaroscopy in 430 patients with rheumatoid arthritis. Caspian J Intern Med 2017 Fall;8(4):269-74.
28. Altomonte L, Zoli A, Galossi A, Mirone L, Tulli A, Martone FR, et al. Microvascular capillaroscopic abnormalities in rheumatoid arthritis patients. Clin Exp Rheumatol 1995 Jan-Feb;13(1):83-6.
29. Lambova SN, Müller-Ladner U. Capillaroscopic pattern in inflammatory arthritis. Microvasc Res 2012 May;830):318-22.
30. Pavlov-Dolijanovic S, Damjanov NS, Stojanovic RM, Vujasinovic Stupar NZ, Stanisavljevic DM. Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int 2012 Oct;32(10):3039-45.
31. Lin KM, Cheng TT, Chen CJ. Clinical Applications of Nailfold Capil-laroscopy in Different Rheumatic Diseases. J Intern Med 2009;20: 238-47.
32. Elliot CA, Hamlin MJ, Lizamore CA. Inter-operator Reliability for Measuring Pulse Wave Velocity and Augmentation Index. Front Cardiovasc Med 2020 Apr 28;7:72.
33. Butlin M, Qasem A. Large Artery Stiffness Assessment Using SphygmoCor Technology. Pulse (Basel) 2017 Jan;4(4):180-92.
34. Doupis J, Papanas N, Cohen A, McFarlan L, Horton E. Pulse Wave Analysis by Applanation Tonometry for the Measurement of Arterial Stiffness. Open Cardiovasc Med J 2016 Aug 31;10:188-95.
35. Sugawara J, Hayashi K, Yokoi T, Tanaka H. Carotid-Femoral Pulse Wave Velocity: Impact of Different Arterial Path Length Measurements. Artery Res 2010 Mar 1;4(1):27-31.
36. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al.; Advisory Board of the 3rd Watching the Risk Symposium 2004, 13th European Stroke Conference. Mannheim intima-media thickness consensus. Cerebrovasc Dis 2004;18(4):346-9.
37. Bots ML, Evans GW, Tegeler CH, Meijer R. Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled
Trials. Chin Med J (Engl) 2016 Jan 20;129(2):215-26.
38. Onut R, Balanescu AP, Constantinescu D, Calmac L, Marinescu M, Dorobantu PM. Imaging Atherosclerosis by Carotid Intima-media Thickness in vivo: How to, Where and in Whom ? Maedica (Bucur) 2012 Jun;7(2):153-62.
39. Arvanitaki A, Giannakoulas G, Triantafyllidou E, Karvounis H, Dim-itroulas T. Peripheral Microangiopathy in Patients with Precapillary Pulmonary Hypertension: Correlation with Cardiac Function and Patients' Functional Capacity. Study Design and Rationale. Mediterr J Rheumatol 2020 Jun 10;31(3):369-73.
40. Thang OH, Serne EH, Grooteman MP, Smulders YM, ter Wee PM, Tangelder GJ, et al. Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels. Nephrol Dial Transplant 2011;26(11):3529-36.
41. van Sloten TT, Czernichow S, Houben AJ, Protogerou AD, Henry RM, Muris DM, et al. Association Between Arterial Stiffness and Skin Microvascular Function: The SUVIMAX2 Study and The Maastricht Study. Am J Hypertension 2015;28(7):868-76.
42. Gronenschild EH, Muris DM, Schram MT, Karaca U, Stehouwer CD, Houben AJ. Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res 2013;90:192-8.
43. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis (Basel, Switzerland) 2012;34(4):290-6.
44. Soulaidopoulos S, Pagkopoulou E, Katsiki N, Triantafyllidou E, Karagiannis A, Garyfallos A, et al. Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study. Arthritis Res Ther 2019;21, 253.
45. Alegre Sancho JJ, Robustillo Villarino M, Albert Espí G, Vergara Dangond C, Vicens Bernabeu E, Valls Pascual É, et al. SAT0197 capillaroscopy and macrovascular disease in patients with systemic sclerosis. Ann Rheum Dis 2016; 75:739.2-739.
46. Schoina M, Loutradis C, Theodorakopoulou M, Dimitroulas T, Tri-antafillidou E, Doumas M, et al. The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease. Microcirculation 2020 Oct 16:e12665.
47. Soper DS. A-priori Sample Size Calculator for Multiple Regression [Software]. 2020. Available from https://www.danielsoper.com/ statcalc.
48. Abramowitz M, Stegun, IA. 1965 Handbook of Mathematical Functions. New York, NY: Dover.
49. Cohen J. 1988 Statistical Power Analysis for the Behavioral Sciences (2nd Edition). Hillsdale, NJ: Lawrence Earlbaum Associates.
50. Cohen J, Cohen P, West SG, Aiken LS. 2003 Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences (3rd edition). Mahwah, NJ: Lawrence Earlbaum Associates.
51. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 Feb 28;15(4):361-87.
